Gonadotropin-releasing hormone for preservation of ovarian function during chemotherapy in lymphoma patients of reproductive age: a summary based on 434 patients.
<h4>Background</h4>Gonadotropin-releasing hormone agonists (GnRHa) might play a role in preserving ovarian function in lymphoma patients by inhibiting chemotherapy-induced ovarian follicular damage. However, studies of its clinical efficacy have reported conflicting results.<h4>Met...
Guardado en:
Autores principales: | Yaoyao Zhang, Zhun Xiao, Yan Wang, Shan Luo, Xiaohong Li, Shangwei Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8fa9ed1e2b514ab9a10d76c043625302 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endocrine and molecular milieus of ovarian follicles are diversely affected by human chorionic gonadotropin and gonadotropin-releasing hormone in prepubertal and mature gilts
por: Adam J. Ziecik, et al.
Publicado: (2021) -
Increased risk of pneumonia in patients receiving gonadotropin-releasing hormone agonists for prostate cancer.
por: Shiu-Dong Chung, et al.
Publicado: (2014) -
Fixed Gonadotropin-Releasing Hormone Antagonist Protocol Versus Flexible Progestin-Primed Ovarian Stimulation Protocol in Patients With Asynchronous Follicular Development During Controlled Ovulation Stimulation: A Retrospective Study
por: Mei Dong, et al.
Publicado: (2021) -
Preserving fertility in young patients with lymphoma: an overview
por: Patel B, et al.
Publicado: (2014) -
Acta Nº434
por: Banco Central de Chile
Publicado: (2019)